Hikma - Half Year Results Interviews With CEO and CFO

LONDON, August 26, 2010 - Hikma Pharmaceuticals reports half year profit growth and raises gross
margin guidance.

In a video interview on www.cantos.com, Hikma CEO Said Darwazah says a
good performance at the company's three divisions supported the results. "All
three engines have been performing quite well, to give us these fantastic
results."

The Generic drugmaker's Chief Financial Officer, Bassam Kaanan, added
that the company was financially strong. "We do have plenty of room to
finance our organic growth and also to move very aggressively on our
acquisition strategy."

The interview and transcript are available now on www.cantos.com.

Cantos.com, the online financial broadcaster, features in-depth
interviews, documentaries and webcasts with senior company executives. If you
would like to contact us, please email amanda.alexander@cantos.com or phone
+44-207-936-1352.

If you would like to contact us, please email amanda.alexander at cantos.com or phone
+44-207-936-1352.